Eisai, Mitsubishi Tanabe See Rapid Generics Business Growth
This article was originally published in PharmAsia News
Executive Summary
Japan's strong demand for generic drugs has benefited brand drug makers such as Eisai and Mitsubishi Tanabe
|
Japan's strong demand for generic drugs has benefited brand drug makers such as Eisai and Mitsubishi Tanabe. Both companies reported over 50 percent growth for generic sales. Eisai generic subsidiary Elmed Eisai increased sales by 62 percent and Tanabe Seiyaku Hanbai jumped by 53 percent. Nippon Chemiphar also reported a 20 percent growth rate. Sawai reported 27 percent growth and Taiyo Pharmaceutical reported 10 percent growth. (Click here for more - Japanese language) "New Drug Makers See Rapid Generics Growth, 62 Percent For Eisai And 54 Percent For Mitsubishi Tanabe" - CB News (11/22/2010) |